Pharma-Bio Serv (PBSV) Cash from Financing Activities (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Cash from Financing Activities came in at -$1.7 million in Q2 2026, up 1.08% YoY from -$1.7 million in Q2 2025, and down 102121.06% on a QoQ basis from -$1681.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has 17 years of Cash from Financing Activities data on file, last reported at -$1.7 million in Q2 2026.
- Quarterly Cash from Financing Activities rose 1.08% year-over-year to -$1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$1.7 million (changed 0.27% YoY) and the FY2025 annual result came in at -$1.8 million, down 1.03% from the prior year.
- Cash from Financing Activities eased to -$1.7 million in Q2 2026, from -$1681.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of -$792.0 in Q4 2023 to a low of -$1.8 million in Q1 2022.
- A 5-year average of -$699441.8 and a median of -$9202.0 in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 62248.3% — and 2023, when it jumped 66.71%.
- Tracing PBSV's Cash from Financing Activities over 5 years: stood at -$2379.0 in 2022, then surged by 66.71% to -$792.0 in 2023, then sank by 120.58% to -$1747.0 in 2024, then slumped by 426.73% to -$9202.0 in 2025, then plunged by 18573.51% to -$1.7 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.7 million (Q2 2026), -$1681.0 (Q1 2026), and -$9202.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -354.13 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -137.18 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 3.02 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | -30.48 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 512.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -7.10 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | -100.55 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.72 Mn |
| Apr 30, 2026 | -1.72 Mn |
| Jan 31, 2026 | -1,681.00 |
| Jan 31, 2026 | -1,681.00 |
| Oct 31, 2025 | -9,202.00 |
| Oct 31, 2025 | -9,202.00 |
| Jul 31, 2025 | -5,004.00 |
| Jul 31, 2025 | -5,004.00 |
| Apr 30, 2025 | -1.74 Mn |
| Apr 30, 2025 | -1.74 Mn |
| Jul 31, 2024 | -1,747.00 |
| Jul 31, 2024 | -1,747.00 |
| Apr 30, 2024 | -1.72 Mn |
| Apr 30, 2024 | -1.72 Mn |
| Jan 31, 2024 | -7,193.00 |
| Jan 31, 2024 | -7,193.00 |
| Oct 31, 2023 | -792.00 |
| Oct 31, 2023 | -792.00 |
| Jul 31, 2023 | -5,083.00 |
| Jul 31, 2023 | -5,083.00 |